DigestRedComo funciona
Red
/
Empresas
Au
No verificado

Aurinia Pharmaceuticals Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

40 Comunicados de prensa

Ver todos los comunicados de prensa
19/08/2026
Mercado laboral
Legislación/Derecho
Asociaciones/Profesionales
Salud
Sanidad
Farmacéutica
Biotecnología
Aurinia Settles Patent Litigation with Teva
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
06/08/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado de valores
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
06/07/2026
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
Industria
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
04/06/2026
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
Industria
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
07/05/2026
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Web y redes sociales
Telefonía
Mercado de valores
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
30/03/2026
Multimedia
Ciencia
Material médico sanitario
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Finanzas
Mercado laboral
Mercado de valores
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
23/03/2026
Biotecnología
Salud
Ciencia
Farmacéutica
Mercado laboral
Aurinia Announces Management Transition
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
26/02/2026
Web y redes sociales
Telefonía
Mercado de valores
Biotecnología
Salud
Ciencia
Farmacéutica
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
19/02/2026
Mercado de valores
Finanzas
Web y redes sociales
Telefonía
Biotecnología
Salud
Ciencia
Farmacéutica
Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0
04/11/2025
Salud
Ciencia
Farmacéutica
Biotecnología
Web y redes sociales
Telefonía
Mercado de valores
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress
Fuente
Aurinia Pharmaceuticals Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0